FDA sees tamper-proof advantage in OxyContin version

09/22/2009 | Google

FDA scientists said a plasticlike coating for Purdue Pharma's painkiller OxyContin offers "limited" tamper-proof qualities, but that the version of the drug might "provide an advantage" over regular OxyContin. A panel of advisers will meet Thursday to review additional data on OxyContin.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY